Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.

Hair loss in male frontal fibrosing alopecia may spare areas covered by a wristwatch.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

FFA has higher long-term remission rates than LPP.

Concentrated growth factors can effectively treat hair loss caused by filler injections.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.